GRAL
GRAL
NASDAQ · Biotechnology

Grail Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$61.64
-1.28 (-2.03%)
As of May 9, 1:21 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 9 75%
Hold 3 25%
Sell 0 0%
Price Target
Analyst Price Target -45.5% upside
Low Target $28.45
Average Target $33.59
High Target $56.21
Current Price $61.64
Current
$61.64
Target
$33.59
$28.45 $33.59 avg $56.21
Scenario Analysis
Bear Case
$28.45
-53.8%
Low target
Base Case
$33.59
-45.5%
Avg target
Bull Case
$56.21
+-8.8%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$118.84
-48.1% from high
52-Week Low
$29.95
+105.8% from low
50-Day SMA
$97.75
-36.9% vs SMA
200-Day SMA
$64.49
-4.4% vs SMA
RSI (14)
50.6
Neutral
Target vs 52W High
$33.59
-71.7% vs high
Next Earnings Report
May 11, 2026
1d
tomorrow
EPS Est: $-2.82
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%